Can a common diabetes drug speed heart and kidney healing?
NCT ID NCT06111768
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 25 times
Summary
This study looks at whether adding a type of diabetes medicine (SGLT2 inhibitors) to standard treatment helps people with sudden heart failure and kidney injury recover faster. It involves 30 adults and focuses on whether such a study is practical and acceptable. The goal is to see if this approach can shorten recovery time and improve kidney function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIORENAL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.